Last reviewed · How we verify
NCT05370534
Smartphone-Based Markerless Motion Capture for Orthopaedic Clinical Use
trial in Musculoskeletal Diseases or Conditions. Withdrawn.
18 December 2023
Quick facts
| Lead sponsor | University of Arkansas |
|---|---|
| Status | Withdrawn |
| Study type | OBSERVATIONAL |
| Start date | 1 December 2023 |
| Primary completion | 18 December 2023 |
| Estimated completion | 18 December 2023 |
| Sites | 1 location across United States |
Conditions studied
- Musculoskeletal Diseases or Conditions — all drugs for Musculoskeletal Diseases or Conditions →
Sponsor
University of Arkansas
Who can join
Adults 18 to 65, any sex, with Musculoskeletal Diseases or Conditions. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
The investigators propose to create a markerless smartphone-based MCA application using AR to measure joint motion and gait patterns to address this technology gap for a simple and inexpensive MCA.
Publications & conference data
No peer-reviewed publications indexed yet for this trial.
Verify or expand the search:
- PubMed search for NCT05370534
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Musculoskeletal Diseases or Conditions
Currently open trials in the same condition.
- NCT07360626 — Exercise and Health Education for Textile Workers: A Pre-Post Study · NA · recruiting
- NCT06773169 — IAMABLE: Implementation and Evaluation of an App for Evidence-Based Self-Management Rehabilitation Strategies · NA · recruiting
- NCT06838793 — ITPB 1 vs 3 in VATS · NA · recruiting
- NCT06594120 — Changes in Workability and Employment Following the Work-related Medical Rehabilitation PV RehaJET · recruiting
- NCT06488547 — Stress and Musculoskeletal Health in Employees · NA · recruiting
Other University of Arkansas trials
Trials by the same sponsor.
- NCT07029776 — MMulti-Immune HR; Multi-Target Immunotherapy for High-Risk Multiple Myeloma · Phase 2 · not yet recruiting
- NCT07341399 — Essential Amino Acid Supplementation in Adult Spinal Deformity Patients · NA · not yet recruiting
- NCT07071766 — Improving Outcomes for Early Postpartum Mothers in Outpatient MOUD Treatment · NA · recruiting
- NCT05823727 — Effects of Collagen Peptide Supplementation on Connective Tissue Remodeling, Functional Outcomes, and Wound Healing Afte · NA · recruiting
- NCT06604065 — Essential Amino Acids and Parkinsons Disease · Phase 1 · withdrawn
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT05370534 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by University of Arkansas
- Last refreshed: 26 December 2023
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05370534.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing